Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy
Nucl. Acids Res. Albertini et al. 34: 1721
Nucl. Acids Res. Albertini et al. 34: 1721
Supplementary Data
Files in this Data Supplement: